Last $2.67 USD
Change Today -0.06 / -2.20%
Volume 29.3K
FCSC On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 1:16 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

fibrocell science inc (FCSC) Snapshot

Open
$2.81
Previous Close
$2.73
Day High
$2.82
Day Low
$2.65
52 Week High
03/14/14 - $6.30
52 Week Low
09/15/14 - $2.60
Market Cap
108.3M
Average Volume 10 Days
82.9K
EPS TTM
$-1.06
Shares Outstanding
40.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FIBROCELL SCIENCE INC (FCSC)

fibrocell science inc (FCSC) Related Bloomberg News

View More Bloomberg News

fibrocell science inc (FCSC) Related Businessweek News

No Related Businessweek News Found

fibrocell science inc (FCSC) Details

Fibrocell Science, Inc., an autologous cell therapy company, focuses on developing various treatments for skin diseases and conditions with unmet medical needs. The company, through its proprietary autologous fibroblast technology, Fibrocell, develops biologic solutions and medical applications of azficel-T for restrictive burn scarring and vocal cord scarring conditions; and biologic products for patients with rare genetic skin and tissue disorders. It has collaboration agreements with Intrexon Corporation for using genetically-modified fibroblasts for treating rare and serious skin, and connective tissue diseases; and University of California, Los Angeles to focus on skin-derived stem cells and other ways to convert skin cells to other cell types. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was founded in 1995 and is headquartered in Exton, Pennsylvania.

58 Employees
Last Reported Date: 06/2/14
Founded in 1995

fibrocell science inc (FCSC) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $454.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $96.9K
Vice President of Human Resources and Busines...
Total Annual Compensation: $199.4K
Vice President of Scientific Affairs
Total Annual Compensation: $188.0K
Vice President of Quality
Total Annual Compensation: $148.8K
Compensation as of Fiscal Year 2013.

fibrocell science inc (FCSC) Key Developments

Fibrocell Science, Inc.(NasdaqCM:FCSC) added to NASDAQ Composite Index

Fibrocell Science, Inc. will be added to the NASDAQ Composite Index.

Fibrocell Science, Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2014

Fibrocell Science, Inc. reported financial results for the second quarter and six months ended June 30, 2014. Net loss for the second quarter ended June 30, 2014 was $2.26 million, or $0.09 loss per diluted share, compared to a net loss of $14.64 million, or $0.63 loss per diluted share, for the same quarter ended June 30, 2013. Revenue from product sales for the second quarter ended June 30, 2014 was $58,000, compared to $62,000 for the same quarter ended June 30, 2013. Net loss for the six months ended June 30, 2014 was $16.27 million, or $0.43 loss per diluted share, compared to a net loss of $19.21 million, or $0.74 loss per diluted share, for the same period ended June 30, 2013. Revenue from product sales for the six months ended June 30, 2014 was $104,000, compared to $88,000 for the same period ended June 30, 2013.

Fibrocell Science, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Fibrocell Science, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported basic net loss of $0.06 per share, compared to basic net loss of $0.63 per share for the same period in 2013. The company used $4.5 million in cash for operations as compared to $5.4 million in the second quarter 2013. For the six months, the company reported basic net loss of $0.40 per share, compared to basic net loss of $0.73 per share for the same period in 2013. The company used $10.2 million in cash for operations as compared to $10.4 million for the comparable period in 2013. The company reported revenue from product sales of $104,000 compared to $88,000 a year ago. Operating loss was $17,596,000 compared to $11,718,000 a year ago. Loss from continuing operations before income taxes was $16,266,000 compared to $19,198,000 a year ago. Net loss was $16,266,000 or $0.43 diluted share compared to $19,207,000 or $0.74 diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FCSC:US $2.67 USD -0.06

FCSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FCSC.
View Industry Companies
 

Industry Analysis

FCSC

Industry Average

Valuation FCSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FIBROCELL SCIENCE INC, please visit www.fibrocellscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.